CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Baxter Healthcare Corporation recalls Cefazolin in Dextrose

Read the official FDA notice

Published
19 Aug 2026
Units affected
19,032 bags
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Brand / company
Baxter Healthcare Corporation
Codes / lots
Lot # LD175708, Exp Date: 14-Feb-2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 19 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.